Veterans Affairs banner with U.S. FlagVeterans Affairs banner with U.S. Flag

Pharmacy Benefits Management Services

VA Center for Medication Safety - A Patient Safety Center for Inquiry


RECENT MEDICATION SAFETY NEWS
Safety Issue Date of Release Safety Information
LIFESCAN OneTouch SureStep Test Strips and Inaccurate Readings – RECALL12/04/2008National PBM Communication
Phenytoin and Fosphenytoin and Serious Skin Reactions12/03/2008National PBM Communication
Erlotinib (Tarceva) and Hepatic Impairment12/01/2008National PBM Communication
ETHEX Recall11/14/2008National PBM Communication
ETHEX Propafenone Recall Patient Letter11/12/2008National PBM Communication
ETHEX Recall11/12/2008National PBM Communication
Concentrated Opioid Solutions and Concentration Confusion11/12/2008National PBM Bulletin
Natalizumab and PML10/31/2008National PBM Communication
Varenicline and Increase in Reports of Serious Adverse Events10/28/2008National PBM Communication
Iron Dextran and the Adverse Drug Events Associated with the High Molecular Weight Formulation  10/21/2008National PBM Bulletin
Calcium and Vitamin D and Change in Formulation10/06/2008National PBM Bulletin
Look-Alike Error with Acetic Acid and Sterile Water Irrigation10/02/2008National PBM Bulletin
Rituximab and PML9/19/2008National PBM Communication
TNF Inhibitors and the Risk for Invasive Fungal Infections09/05/2008National PBM Bulletin
EPOGEN® and Amgen Announcing Nationwide Voluntary Recall08/28/2008Patient Letter
EPOGEN® and Amgen Announcing Nationwide Voluntary Recall08/28/2008National PBM Communication
Natalizumab and PML08/27/2008National PBM Communication
Ezetimibe/Simvastatin (Vytorin®), Simvastatin, and Ezetimibe (Zetia®) and Risk for Cancer08/26/2008National PBM Communication
Naltrexone Injection Site Reactions08/20/2008National PBM Alert
Exenatide (Byetta) and Hemorrhagic and Necrotizing Pancreatitis08/19/2008National PBM Response
Naltrexone Injection Site Reactions8/20/2008National PBM Alert
Simvastatin and Amiodarone Drug-Drug Interaction8/18/2008National PBM Response
Mitoxantrone and Recommendations for Increased Monitoring8/18/2008National PBM Response
PROCRIT® (EPOETIN ALFA) LOT NUMBER P114942A and Nationwide Voluntary Recall of Ortho Biotech8/8/2008National PBM Response
PROCRIT® (EPOETIN ALFA) LOT NUMBER P114942A and Nationwide Voluntary Recall of Ortho Biotech – Patient Letter8/8/2008Patient Letter
Erythropoiesis Stimulating Agents (ESAs ):  FDA Labeling Changes for Cancer Patients Receiving Myelosuppressive Chemotherapy8/8/2008National PBM Update Alert
Topical Thrombin and Safety Issues if Used Intravascularly8/7/2008National PBM Alert
Bevacizumab Plus Sunitinib and Potential for Developing Microangiopathic Hemolytic Anemia7/31/2008National PBM Alert
Micro-Bubble Contrast Agents (Definity® [Perflutren Lipid Microsphere] Injectable Suspension and Optison® [Perflutren Protein-Type A Microspheres] for Injection): Risk of Cardiopulmonary Reactions and Changes to Package Labeling7/18/2008National PBM Alert
Nationwide Recall of Sodium Polystyrene Sulfonate Suspension, USP (15g/60ml) (NDC 0054-0165-51; Lot 856396A Expiration April 2010, and Lot 856693A ExpirationMay 2010)7/17/2008National PBM Alert
Nationwide Recall of Sodium Polystyrene Sulfonate Suspension, USP (15g/60ml) (NDC 0054-0165-51; Lot 856396A Expiration April 2010, and Lot 856693A ExpirationMay 2010)7/17/2008Patient Letter
Fluoroquinolone Use and the Potential for Tendinitis and Tendon Rupture7/10/2008National PBM Bulletin
CellCept® (mycophenolate mofetil) and Cases of Progressive Multifocal Leukoencephalopathy (PML)7/1/2008National PBM Bulletin



PBM Home | Clinical Guidance | Drug Monographs
Drug Prices, Contracts & Agreements | Education | Links & Other Resources
National Formulary | News & Bulletins | VA Center for Medication Safety


If you have a question pertaining to this website and only information contained in this website, please contact the PBM Webmaster. Please note: For questions pertaining to Health Care Benefits, please visit http://www.va.gov/Health_Benefits/. For questions pertaining to prescription renewal, please visit https://www.myhealth.va.gov/. Questions pertaining to your drug therapy or other medical questions should be referred directly to your Health Care Providers located at the VA facilities where you receive care.